A new Epstein-Barr virus negative Burkitt's lymphoma derived cell-line. I. Analysis of cell surface markers and abnormal expression of HLA antigens.

CHEV, a new Epstein-Barr virus negative Burkitt's lymphoma derived cell line has been studied. Karyotype analyses demonstrated the t (8; 14) characteristic translocation. Cell surface characterisation of this line showed the presence of mu and chi immunoglobulin chains and beta 2-microglobulin and the absence of the complement receptor. We are unable to detect HLA--A, B alloantigens on the cell surface which was in contrast with an apparently normal expression of these antigens in the cytoplasm.

[1]  H. Yamamoto,et al.  Relationship between carcinoembryonic antigen and major histocompatibility antigens on cultured human carcinoma cells. , 1980, Journal of immunology.

[2]  M. Fellous,et al.  Reactivity of Human Lymphoid and Lymphoblastoid Cells with Peanut Agglutinin: Detection of a Blood Cell Subset which Lacks Detectable Membrane HLA , 1980, Scandinavian journal of immunology.

[3]  M. Epstein,et al.  HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells , 1980, Nature.

[4]  M. Lipinski,et al.  Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA- linked control at the effector level , 1979, The Journal of experimental medicine.

[5]  P. Schellekens,et al.  Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency. , 1979, Clinical immunology and immunopathology.

[6]  R. Berger,et al.  Cytogenetic study of a European Burkitt's lymphoma cell line. , 1979, Journal of the National Cancer Institute.

[7]  H. Ploegh,et al.  Cell-free translation of the mRNAs for the heavy and light chains of HLA-A and HLA-B antigens. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Mason,et al.  The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells , 1979, European journal of immunology.

[9]  G. Ferrara,et al.  Immunological dissection of human Ia molecules , 1978, The Journal of experimental medicine.

[10]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[11]  C. Barnstable,et al.  The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. , 1978, Tissue antigens.

[12]  P. Avner,et al.  Isolation of a human teratoma cell line which expresses F9 antigen , 1977, Nature.

[13]  W. Fridman,et al.  Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis , 1977, Nature.

[14]  P. Lydyard,et al.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG , 1977, The Journal of experimental medicine.

[15]  D. Solter,et al.  H–2 gene expression is required for T cell-mediated lysis of virus-infected target cells , 1977, Nature.

[16]  G. Klein,et al.  Somatic cell hybrids between human lymphoma lines. III. Surface markers , 1977, International journal of cancer.

[17]  P. Goodfellow,et al.  EXPRESSION OF HLA SYSTEM ANTIGENS ON PLACENTA , 1976, Transplantation.

[18]  G. Klein,et al.  Inducibility of the Epstein‐Barr virus (EBV) cycle and surface marker properties of ebv‐negative lymphoma lines and their in vitro EBV‐converted sublines , 1976, International journal of cancer.

[19]  G. Klein,et al.  Epithelial Characteristics of Tumor Cells in Nasopharyngeal Carcinoma Passaged in Nude Mice: Ultrastructure , 1976 .

[20]  G. Flandrin,et al.  Immunological Classification of Acute Lymphoblastic Leukaemias: Evaluation of its Clinical Significance in a Hundred Patients , 1976, British journal of haematology.

[21]  G. Klein,et al.  Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines , 1976, International journal of cancer.

[22]  G. Klein,et al.  Surface Markers on Human B and T Lymphocytes , 1976, Scandinavian journal of immunology.

[23]  K. Lennert,et al.  Attempts to demonstrate virus‐specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis , 1976, International journal of cancer.

[24]  N. Day,et al.  Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients , 1975, International journal of cancer.

[25]  M. Jondal,et al.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Klein,et al.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Artzt,et al.  Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. , 1974, Transplantation.

[28]  J. Kersey,et al.  Transplantation antigens (H-2) on virally and chemically transformed BALB-3T3 fibroblasts in culture. , 1974, Journal of the National Cancer Institute.

[29]  S. Goldstein,et al.  Absence of detectable HL-A antigens on cultured fibroblasts in progeria. , 1973, The Journal of clinical investigation.

[30]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[31]  G. Klein,et al.  Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. , 1973, Journal of the National Cancer Institute.

[32]  B. Lilliehöök,et al.  Evidence for non-exposed H-2 antigens in immunoresistant murine tumour. , 1973, Nature: New biology.

[33]  S. Ferrone,et al.  A rapid method for direct HL-A typing of cultured lymphoid cells. , 1971, Journal of immunology.

[34]  R. Herberman,et al.  Inverse relationship of polyoma tumour specific cell surface antigen to H-2 histocompatibility antigens. , 1971, Nature: New biology.

[35]  C. Mckhann,et al.  ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS , 1971, The Journal of experimental medicine.

[36]  V. Nussenzweig,et al.  A POPULATION OF LYMPHOCYTES BEARING A MEMBRANE RECEPTOR FOR ANTIGEN-ANTIBODY-COMPLEMENT COMPLEXES , 1970, The Journal of experimental medicine.

[37]  G. Klein,et al.  SURFACE IgM SPECIFICITY ON CELLS DERIVED FROM A BURKITT'S LYMPHOMA , 1967 .

[38]  H. Bétuel,et al.  Absence of cell-membrane HLA antigens in an immunodeficient child. , 1978, Tissue antigens.